PRIME November/December 2025 issue
(more…)...
Read More
Author: Balraj Juttla
RF Microneedling Safety Comes into Question
On October 15, the U.S. Food and Drug Administration (FDA) issued a safety communication on the potential risks with dermatologic and aesthetic uses of radiofrequency (RF) microneedling. Physicians who use the technology put the news into perspective and offer best practices.
Read More
Injectable and Topical Peptides in Aesthetic Medicine Mechanisms, Clinical Applications, and Future Potential
From collagen stimulation to fat metabolism and neuroregeneration, peptides are redefining aesthetic practice. Raheleh Sarbaziha, MD, and David J. Goldberg, MD, explore their mechanisms, delivery routes, and clinical synergy
Read MoreProfhilo® Enters New Chapter: IBSA to Lead UK & Ireland Distribution from 2026 After 10 Years of HA-Derma Expertise
IBSA UK&I, the UK and Ireland subsidiary of global pharmaceutical leader IBSA, today announces it will assume full responsibility for the distribution, training and support of its aesthetic medicine portfolio...
Read More
Smart Skin Synergy: Pairing Mesotherapy with Energy Devices
PRIME explores how practitioners are combining mesotherapy with energy-based technologies to deliver enhanced skin rejuvenation results with minimal downtime, improved precision, and better outcomes
Read More
Need Tissue? Bioprinting Could be the Solution
3D bioprinted skin is advancing in studies with the potential to become a
next-generation solution in aesthetics and regenerative medicine
Healing Matters: The Rise of Medical-Grade Aftercare
Advanced treatments demand clinical-grade recovery — epicite® CALM meets the
moment with sterile, soothing care
PRIME Sept/Oct 2025
(more…)
Read MoreMarch/April 2026 Issue
